APA

van Lierop A. H., van der Eerden A. W., Hamdy N. A. T., Hermus A. R., den Heijer M. & Papapoulos S. E. (20121218). Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. : The Journal of clinical endocrinology and metabolism.

Chicago

van Lierop A H, van der Eerden A W, Hamdy N A T, Hermus A R, den Heijer M and Papapoulos S E. 20121218. Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. : The Journal of clinical endocrinology and metabolism.

Harvard

van Lierop A. H., van der Eerden A. W., Hamdy N. A. T., Hermus A. R., den Heijer M. and Papapoulos S. E. (20121218). Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. : The Journal of clinical endocrinology and metabolism.

MLA

van Lierop A H, van der Eerden A W, Hamdy N A T, Hermus A R, den Heijer M and Papapoulos S E. Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. : The Journal of clinical endocrinology and metabolism. 20121218.